MG

Manish Gangwar

Active Director Director DIN 09088832
DIN 09088832 First appointment Mar 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Manish Gangwar

Data last updated:

Manish Gangwar is a Director at Philanthropy Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Philanthropy Pharmaceuticals Private Limited reported revenue of ₹5,652 (FY 2024).

DIN 09088832
Primary Designation Director
Industry Trading
First Appointment 03 Mar 2021
Oldest Company Age 5 yrs
Largest company Philanthropy Pharmaceuticals Private Limited · ₹5,652 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Mar 20212021₹5,652 (FY 2024)Active

Board colleagues of Manish Gangwar

Directorship timeline

Open interactive timeline →
Philanthropy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manish Gangwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Gangwar

Manish Gangwar currently holds 1 directorship: Philanthropy Pharmaceuticals Private Limited (Director, since 03 Mar 2021, revenue ₹5,652 (FY 2024)).

Manish Gangwar was first appointed on 03 Mar 2021 as Director at Philanthropy Pharmaceuticals Private Limited.

The current boards of Manish Gangwar's companies include Anshul Sharma (Philanthropy Pharmaceuticals Private Limited), Indu Bala (Philanthropy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available